Cardiovascular calcification management deals with preventing and treating the abnormal buildup of calcium inside arteries and valves of the heart through drugs, procedures, lifestyle changes and diet. Calcification occurs due to excess calcium deposits that accumulate over time and stiffen arteries and cardiac valves, increasing the risk of heart attacks and strokes.
Cardiovascular calcification management includes medications like bisphosphonates, therapies like coronary artery calcium scoring and valve replacement surgeries. With rising lifestyle diseases and aging population worldwide, Cardiovascular calcification has become a major public health concern.
The cardiovascular calcification market is estimated to be valued at USD 125.2 billion in 2024 and is expected to reach USD 174.6 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Key Takeaways
Key players in cardiovascular calcification management include Pfizer, Amgen, GlaxoSmithKline, Novartis, Merck and Bayer. These companies offer a diverse portfolio of drugs and procedures for calcification management.
Increasing research focus on novel therapeutics presents significant opportunities in Cardiovascular Calcification Market management. Companies are developing new drugs targeting mechanisms behind arterial stiffening and abnormal calcification buildup.
North America currently dominates the global market due to high disease prevalence and accessibility of advanced treatments. However, Asia Pacific is expected to witness fastest growth over the forecast period driven by expanding medical infrastructure and growing health awareness in developing nations.
Market Drivers
Rising prevalence of cardiovascular diseases globally is a major factor driving increased demand for cardiovascular calcification management. Conditions like coronary artery disease, heart failure, stroke that can lead to calcification are on the rise worldwide. According to WHO, cardiovascular diseases account for over 17 million deaths annually. Growing geriatric population also boosts market growth as aging is a major risk factor for excess calcification. Older adults are more prone to arterial stiffening and cardiac valve calcification over time if left untreated. People over 60 years comprised about 12.5% of the global population in 2020 and this number is estimated to rise to 16.5% by 2050.
PEST Analysis Political: Regulations relating to healthcare and clinical research aid the growth of this market. New policies can impact research funding and product approvals.
Economic: Growth in disposable incomes increases healthcare spending and demand for better diagnostic solutions. Economic downturns may temporarily lower diagnostic spending.
Social: Aging population and increasing lifestyle diseases like diabetes drive the need for early diagnosis and management of cardiovascular conditions.Greater health awareness boosts preventive healthcare adoption.
Technological: Advancements in imaging techniques improve detection accuracy. Digital systems enable storage and sharing of scan results over networks. Integration of AI can help automate analysis and detect subtle anomalies.
Regions of Concentration Geographically, the market is concentrated in developed countries in North America and Western Europe due to higher healthcare spending and advanced healthcare infrastructure in these regions. The large elderly population make the US and key European markets the largest currently in terms of value. However Asia Pacific region is witnessing faster growth led by China and India on account of rising middle class population seeking improved care.
Fastest Growing Region The Asia Pacific region is expected to experience the fastest growth over the forecast period among all regions. This is attributed to growing geriatric patient pool, increasing uptake of modern diagnostic tools and expanding healthcare infrastructure. Rapid economic development is enabling Asian nations to invest more in healthcare sectors. Emerging Asia Pacific markets like China and India are poised to drive significant future demand for cardiovascular calcification assessment products.
Explore additional details from the source — The Growing Cardiovascular Calcification Market is Trending due to Increasing CVD Cases Globally
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163
